PXD055375 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Targets of histone deacetylase inhibitors in ovarian cancer identified using proteome integral solubility alteration |
Description | Using proteome integral solubility alteration (PISA) to assess HDAC inhibitor targets across ovarian cancer and acute lymphoblastic leukemia cell types |
HostingRepository | PRIDE |
AnnounceDate | 2024-12-19 |
AnnouncementXML | Submission_2024-12-19_12:08:52.530.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Jolene Duda |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | TMT6plex-126 reporter+balance reagent acylated residue |
Instrument | Q Exactive Plus |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2024-08-30 00:33:59 | ID requested | |
⏵ 1 | 2024-12-19 12:08:52 | announced | |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: cancer,PISA, HDAC inhibitor, HDAC, HGSOC, thermal profiling, ALL |
Contact List
Stefani Thomas |
contact affiliation | University of Minnesota Department of Lab Medicine and Pathology |
contact email | stefanit@umn.edu |
lab head | |
Jolene Duda |
contact affiliation | University of Minnesota |
contact email | duda0032@umn.edu |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/12/PXD055375 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD055375
- Label: PRIDE project
- Name: Targets of histone deacetylase inhibitors in ovarian cancer identified using proteome integral solubility alteration